sertindole has been researched along with Cardiovascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karamatskos, E; Lambert, M; Mulert, C; Naber, D | 1 |
| Perquin, L; Steinert, T | 1 |
| Azorin, JM; Cochran, J; Moore, N; Peuskens, J; Toumi, M | 1 |
2 review(s) available for sertindole and Cardiovascular Diseases
| Article | Year |
|---|---|
Drug safety and efficacy evaluation of sertindole for schizophrenia.
Topics: Animals; Antipsychotic Agents; Cardiovascular Diseases; Dose-Response Relationship, Drug; Electrocardiography; Humans; Imidazoles; Indoles; Randomized Controlled Trials as Topic; Risk Factors; Schizophrenia | 2012 |
A review of the efficacy, tolerability and safety of sertindole in clinical trials.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Cardiovascular Diseases; Clinical Trials as Topic; Cognition; Drug Tolerance; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Suicide; Treatment Outcome | 2004 |
1 other study(ies) available for sertindole and Cardiovascular Diseases
| Article | Year |
|---|---|
The European sertindole safety and exposure survey: a follow-up study of 8600 patients.
Topics: Adult; Age Factors; Antipsychotic Agents; Cardiovascular Diseases; Case-Control Studies; Death, Sudden, Cardiac; Europe; Female; Follow-Up Studies; Heart Diseases; Humans; Imidazoles; Indoles; Male; Metabolic Diseases; Middle Aged; Risk Factors; Sex Factors; Suicide | 2007 |